Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk from 5 Prospective Cohorts.

MLA

Lee, Alice A., et al. “Helicobacter Pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk from 5 Prospective Cohorts.” Clinical & Translational Gastroenterology, vol. 14, no. 3, Mar. 2023, pp. 1–24. EBSCOhost, https://doi.org/10.14309/ctg.0000000000000573.

APA

Lee, A. A., Wang, Q.-L., Kim, J., Babic, A., Zhang, X., Perez, K., Ng, K., Nowak, J., Rifai, N., Sesso, H. D., Buring, J. E., Anderson, G. L., Wactawski-Wende, J., Wallace, R., Manson, J. E., Giovannucci, E. L., Stampfer, M. J., Kraft, P., Fuchs, C. S., & Yuan, C. (2023). Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk from 5 Prospective Cohorts. Clinical & Translational Gastroenterology, 14(3), 1–24. https://doi.org/10.14309/ctg.0000000000000573

Chicago

Lee, Alice A., Qiao-Li Wang, Jihye Kim, Ana Babic, Xuehong Zhang, Kimberly Perez, Kimmie Ng, et al. 2023. “Helicobacter Pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk from 5 Prospective Cohorts.” Clinical & Translational Gastroenterology 14 (3): 1–24. doi:10.14309/ctg.0000000000000573.